DMTK
Income statement / Annual
Last year (2023), DermTech, Inc.'s total revenue was $15.30 M,
an increase of 5.36% from the previous year.
In 2023, DermTech, Inc.'s net income was -$100.89 M.
See DermTech, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2013
|
FY-2012
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
03/31/2018 |
03/31/2017 |
12/31/2013 |
12/31/2012 |
| Operating Revenue |
$15.30 M |
$14.52 M |
$11.84 M |
$5.89 M |
$3.36 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$15.02 M
|
$13.87 M
|
$10.56 M
|
$5.98 M
|
$3.30 M
|
$306.24 K
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$276.00 K
|
$647.00 K
|
$1.27 M
|
-$96.00 K
|
$60.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0.02
|
0.04
|
0.11
|
-0.02
|
0.02
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$15.24 M
|
$24.05 M
|
$16.26 M
|
$5.29 M
|
$2.50 M
|
$2.05 M
|
$2.00 M
|
$1.96 M
|
$975.84 K
|
| General & Administrative Expenses |
$43.78 M
|
$36.09 M
|
$24.84 M
|
$13.82 M
|
$8.87 M
|
$0.00
|
$0.00
|
$1.27 M
|
$1.06 M
|
| Selling & Marketing Expenses |
$45.00 M
|
$58.67 M
|
$37.58 M
|
$16.08 M
|
$6.30 M
|
$0.00
|
$0.00
|
$31.48 K
|
$126.04 K
|
| Selling, General & Administrative Expenses |
$88.78 M
|
$94.76 M
|
$62.41 M
|
$29.90 M
|
$15.17 M
|
$6.32 M
|
$306.24 K
|
$1.30 M
|
$1.19 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$355.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$104.02 M
|
$118.81 M
|
$78.67 M
|
$35.19 M
|
$17.67 M
|
$8.73 M
|
$306.24 K
|
$3.26 M
|
$2.17 M
|
| Cost And Expenses |
$119.04 M
|
$132.68 M
|
$89.24 M
|
$41.17 M
|
$20.97 M
|
$306.24 K
|
$306.24 K
|
$3.26 M
|
$2.17 M
|
| Interest Income |
$2.85 M
|
$1.34 M
|
$151.00 K
|
$40.00 K
|
$0.00
|
$1.09 M
|
$0.00
|
$1.92 M
|
$61.80 K
|
| Interest Expense |
$0.00
|
$1.34 M
|
$0.00
|
$40.00 K
|
$2.66 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$5.85 M
|
-$141.00 K
|
$1.09 M
|
$486.00 K
|
$89.00 K
|
$45.42 K
|
$52.52 K
|
$18.76 K
|
$54.06 K
|
| EBITDA |
-$97.89 M |
-$113.85 M |
-$74.01 M |
-$35.29 M |
-$17.96 M |
-$261.00 K |
-$60.00 |
-$3.24 M |
-$2.11 M |
| EBITDA Ratio |
-6.4
|
-7.84
|
-6.25
|
-6
|
-5.34
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-6.78
|
-8.14
|
-6.54
|
-6
|
-5.23
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$2.85 M
|
$1.48 M
|
-$937.00 K
|
-$1.19 M
|
-$2.08 M
|
$1.56 M
|
$306.18 K
|
-$1.92 M
|
-$61.80 K
|
| Income Before Tax |
-$100.89 M
|
-$116.68 M
|
-$78.34 M
|
-$36.48 M
|
-$19.69 M
|
$944.46 K
|
-$60.00
|
-$5.18 M
|
-$2.23 M
|
| Income Before Tax Ratio |
-6.6
|
-8.04
|
-6.62
|
-6.2
|
-5.85
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
-$2.96 M
|
-$1.36 M
|
-$526.00 K
|
$2.21 M
|
-$1.16 M
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$100.89 M
|
-$116.68 M
|
-$78.34 M
|
-$36.48 M
|
-$21.90 M
|
$856.41 K
|
-$60.00
|
-$5.18 M
|
-$2.23 M
|
| Net Income Ratio |
-6.6
|
-8.04
|
-6.62
|
-6.2
|
-6.51
|
0
|
0
|
0
|
0
|
| EPS |
-3.09 |
-3.88 |
-2.71 |
-2.05 |
-3.13 |
0.36 |
0 |
-1.1 |
-0.65 |
| EPS Diluted |
-3.09 |
-3.88 |
-2.71 |
-2.05 |
-3.13 |
0.36 |
0 |
-1.1 |
-0.65 |
| Weighted Average Shares Out |
$32.64 M
|
$30.04 M
|
$28.89 M
|
$16.98 M
|
$7.01 M
|
$2.36 M
|
$1.82 M
|
$4.72 M
|
$3.44 M
|
| Weighted Average Shares Out Diluted |
$32.64 M
|
$30.04 M
|
$28.89 M
|
$16.98 M
|
$7.01 M
|
$2.36 M
|
$8.07 M
|
$4.72 M
|
$3.44 M
|
| Link |
|
|
|
|
|
|
|
|
|
